Project Details
| Short title | NIAGARA |
|---|---|
| Status | Finished |
| Effective start/end date | 10/10/18 → 6/10/23 |
A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients with Muscle-Invasive Bladder Cancer
- Gurney, Howard (Primary Chief Investigator)
- Cunningham, Jacob (Research Assistant)
- Butala, Radhika (Research Assistant)
Project: Other